A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathy.
about
Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system.Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.
P2860
A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A novel cytarabine crystalline ...... oliferative vitreoretinopathy.
@en
A novel cytarabine crystalline ...... oliferative vitreoretinopathy.
@nl
type
label
A novel cytarabine crystalline ...... oliferative vitreoretinopathy.
@en
A novel cytarabine crystalline ...... oliferative vitreoretinopathy.
@nl
prefLabel
A novel cytarabine crystalline ...... oliferative vitreoretinopathy.
@en
A novel cytarabine crystalline ...... oliferative vitreoretinopathy.
@nl
P2093
P2860
P1433
P1476
A novel cytarabine crystalline ...... roliferative vitreoretinopathy
@en
P2093
Igor Kozak
Jae Suk Kim
James R Beadle
Julissa Trahan
Karl Y Hostetler
Kathrin Hartmann
Kathy A Aldern
Laura Conner
Lingyun Cheng
Nadejda Valiaeva
P2860
P304
P577
2012-07-14T00:00:00Z